# Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)

> **NCT07180147** · — · ACTIVE_NOT_RECRUITING · sponsor: **Marymount University** · enrollment: 500 (estimated)

## Conditions studied

- Alzheimer Disease (AD)
- Cardio Vascular Disease
- Mild Cognitive Impairment (MCI)
- Frailty Syndrome
- Disability Physical
- Hypertension
- Metabolic Syndrome (MetS)
- Healthy Aging
- Obesity &Amp; Overweight

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07180147
- **Lead sponsor:** Marymount University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2030-12-30
- **Final completion:** 2031-07-30
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07180147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07180147, "Arlington Longitudinal Optimal Healthy Aging Study (ALOHA)". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07180147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*